Supply Chain News

Mislabeled Packaging Results in Recalled ADHD Medication

February 1, 2024 - On January 24, 2024, Azurity Pharmaceuticals sent an announcement to the United States FDA recalling Zenzedi, a brand name for 30 mg dextroamphetamine sulfate tablets, for mislabeled packaging. The recall applies to the F230169A lot, which was shipped between August 23, 2023, and November 29, 2023, with an expiration date of July 2025. The...

Read More


Articles

HHS and Pfizer Reach Paxlovid Agreement to Improve Access

by

Last week, the United States Department of Health and Human Services (HHS) announced that it had negotiated an agreement with Pfizer Inc. to bolster access to Paxlovid as it enters the commercial...

US Continues to Increase Its Reliance on Chinese Pharma Supply Chain

by

According to research from the Atlantic Council, pharmaceutical products have become a valuable part of the United States and China’s trading relationship, growing from 0.6% of the total trade to...

Liquid Albuterol Shortages Exacerbated by Supply Chain Issues

by

Last month, WAND reported that Akorn Pharmaceuticals, a major domestic manufacturer of liquid albuterol, was shutting down. This closure — which followed 2020 reports that the company filed for...

Navigating Cold and Flu Medication Shortages

by

In recent months, patients, parents, and providers have become increasingly aware of the rise in viral infection rates. With the tripledemic — including COVID-19, respiratory syncytial virus...

Pfizer Invests $750M in Michigan Pharmaceutical Manufacturing Expansion

by

Pfizer is investing $750 million to expand its primary manufacturing facility in Kalamazoo, Michigan. The expansion will allow the pharmaceutical company to increase the production of vaccines and...

Biden Administration Secures COVID-19 Booster Shots for Use This Fall

by

The Biden Administration is preparing for a potential coronavirus surge this fall by purchasing millions of variant-specific COVID-19 booster shots. In addition to the 105 million doses already...

$354M BARDA Contract for Pharmaceutical Manufacturing Goes Unfulfilled

by

In May 2020, Phlow Corp. received $354 million to bring inexpensive generic pharmaceutical manufacturing to the United States. At the time, it was one of the largest coronavirus-era contracts to be...

Nephron Pharmaceuticals Recalls 2.1 Million Doses of Medicine, Medical Equipment

by

According to the FDA’s enforcement report, Nephron Sterile Compounding Center, in Columbia, South Carolina, is recalling 2,158,351 medical products including syringes and bags because of a lack...

Eli Lilly Invest $2.1B in Indiana Pharmaceutical Manufacturing

by

Pharmaceutical giant, Eli Lilly, will extend its operations in Indiana, adding two additional manufacturing facilities with a $2.1 billion investment. Lilly will use the new facilities to produce...

Hospital Contrast Dye Shortage Results in Rationed Medical Imaging Care

by

In the United States and worldwide, hospitals are experiencing a shortage of critical iodinated contrast media — also called contrast dye — a nontoxic, contrasting agent that radiologists...

Sandoz Expands Collaboration in Antimicrobial Resistance Fight

by

Sandoz recently expanded its strategic collaboration agreement with Ares Genetics (Ares) to drive cutting-edge digital solutions in the global fight against antimicrobial resistance (AMR).  The...

Gilead Boosts Oncology Pipeline With 3 Clinical-Stage Programs

by

Gilead recently added three programs in Arcus Biosciences’ clinical-stage portfolio, including antibodies and small molecules, to its oncology pipeline. Specifically, Gilead exercised its...

Biden Pushes Policy Changes to Protect Pharmaceutical Supply Chain

by

The White House, the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), and FDA recently released policy recommendations to protect US pharmaceutical supply chains.  The...

CVS Caremark Prescription Drug Trend Rose to 2.9% in 2020

by

CVS Caremark recently announced that its overall prescription drug trend for 2020 was 2.9 percent, while there was a negative trend for 34 percent of commercial pharmacy benefit management (PBM)...

Northwell, Pear Therapeutics Provide New Opioid Treatment Options

by

Northwell Health and Pear Therapeutics recently collaborated to provide new treatment options for patients with opioid and substance-use disorders.  Through the collaboration, patients seeking...

Health2047 to Improve Clinical Trial Access with New Venture

by

Health2047, a subsidiary of the American Medical Association (AMA), recently spun out SiteBridge Research to boost clinical trial access for small and community physician practices.  SiteBridge...

GE Gets $41M to Accelerate Vaccine Manufacturing, Distribution

by

GE Research and a multi-disciplinary team are receiving up to $41 million over the next five years to boost nucleic acid-based vaccine manufacturing and distribution.  The Defense Advanced...

Merck to Manufacture Johnson & Johnson COVID-19 Vaccine for US

by

The Biden Administration recently announced a historic collaboration between Johnson & Johnson and Merck to expand production of Johnson & Johnson’s COVID-19 vaccine,...

AstraZeneca Furthers COVID-19 Vaccine Rollout Through COVAX

by

AstraZeneca recently announced that the first doses of its COVID-19 vaccine through the COVAX initiative have begun arriving in low and middle-income countries globally.  The first shipments were...

Recent Articles